Literature DB >> 25076791

Influence of Mifepristone in Induction Time for Terminations in the Second and Third Trimester.

M Hoopmann1, J Hirneth1, J Pauluschke-Fröhlich1, B Yazdi1, H Abele1, D Wallwiener1, K O Kagan1.   

Abstract

Termination of pregnancy after the first trimester is generally carried out by medical induction. Question: The aim of this study is to investigate the effect of mifepristone before administration of the prostaglandin derivative on induction time. Material and
Methods: We analysed 333 medically indicated terminations after the first trimester under the terms of § 218 a Para. 2 of the German Criminal Code, in which the prostaglandin derivatives misoprostol, gemeprost or dinoprostone were administered with or without pre-treatment with 600 mg of mifepristone. The time interval between the initial administration of prostaglandin and delivery was investigated. Using uni- and multivariate regression analysis, the effect of maternal age, body mass index, gravidity and parity, previous Caesarean sections, gestational age and the induction regimen on the induction time were analysed.
Results: The average induction time was significantly shortened with mifepristone (15.1 ± 11.9 hours with mifepristone vs. 25.3 ± 24.2 hours without mifepristone [p < 0.001]). The combination of mifepristone and misoprostol was most frequently used and proved to be the most effective regimen, reducing the induction period to 13.6 ± 10.3 hours. Besides pre-treatment with mifepristone, gestational age and a history of delivery without Caesarean section were significant influencing factors in reducing the induction time.
Conclusion: The induction interval can be significantly shortened by the prior administration of mifepristone. The combination of mifepristone and misoprostol or gemeprost is the most effective regimen for the medical termination of pregnancy.

Entities:  

Keywords:  dinoprostone; gemeprost; mifepristone; misoprostol; termination

Year:  2014        PMID: 25076791      PMCID: PMC4078152          DOI: 10.1055/s-0033-1360361

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  16 in total

Review 1.  Termination of pregnancy--a global view.

Authors:  S J Segal; K D LaGuardia
Journal:  Baillieres Clin Obstet Gynaecol       Date:  1990-06

2.  Factors influencing the duration of late first and second-trimester termination of pregnancy with prostaglandin derivates.

Authors:  Norbert Wagner; Harald Abele; Markus Hoopmann; Eva-Maria Grischke; Gunnar Blumenstock; Diethelm Wallwiener; Karl Oliver Kagan
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2010-11-26       Impact factor: 2.435

Review 3.  Recent advances in second-trimester abortion: an evidence-based review.

Authors:  Cassing Hammond
Journal:  Am J Obstet Gynecol       Date:  2009-04       Impact factor: 8.661

4.  Termination of second trimester pregnancy with gemeprost and misoprostol: a randomized double-blind placebo-controlled trial.

Authors:  K S Wong; C S Ngai; K S Chan; L C Tang; P C Ho
Journal:  Contraception       Date:  1996-07       Impact factor: 3.375

5.  Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial.

Authors:  Nguyen Thi Nhu Ngoc; Tara Shochet; Sheila Raghavan; Jennifer Blum; Nguyen Thi Bach Nga; Nguyen Thi Hong Minh; Van Quy Phan; Beverly Winikoff
Journal:  Obstet Gynecol       Date:  2011-09       Impact factor: 7.661

6.  Clinical guidelines. Labor induction abortion in the second trimester.

Authors:  Lynn Borgatta; Nathalie Kapp
Journal:  Contraception       Date:  2011-03-30       Impact factor: 3.375

7.  Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostol.

Authors:  D Jannet; N Aflak; A Abankwa; B Carbonne; L Marpeau; J Milliez
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1996-12-27       Impact factor: 2.435

8.  Factors influencing the duration of pregnancy termination with vaginal misoprostol for fetal abnormality.

Authors:  Jan E Dickinson; Dorota A Doherty
Journal:  Prenat Diagn       Date:  2009-05       Impact factor: 3.050

9.  Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial.

Authors:  Helena von Hertzen; Gilda Piaggio; Daniel Wojdyla; Thi My Huong Nguyen; Lena Marions; Georgy Okoev; Archil Khomassuridze; Attila Kereszturi; Suneeta Mittal; Rajasekharan Nair; Rekha Daver; Alenka Pretnar-Darovec; Kim Dickson; Duc Hinh Nguyen; Huy Bao Nguyen; Thi Diem Tuyet Hoang; Alexandre Peregoudov
Journal:  Hum Reprod       Date:  2008-09-14       Impact factor: 6.918

10.  Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.

Authors:  Hani A Akoury; Mary E Hannah; David Chitayat; Martin Thomas; Elizabeth Winsor; Lorraine E Ferris; Thomas R Einarson; P G R Seaward; Greg Ryan; Andrew R Willan; Rory Windrim
Journal:  Am J Obstet Gynecol       Date:  2004-03       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.